|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,438.00 INR | -5.03% |
|
+1.57% | +5.39% |
Company Valuation: Emcure Pharmaceuticals Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Capitalization 1 | 2,03,202 | 2,76,497 | - | - |
| Change | - | 36.07% | - | - |
| Enterprise Value (EV) 1 | 2,08,106 | 2,83,239 | 2,78,620 | 2,70,003 |
| Change | - | 36.1% | -1.63% | -3.09% |
| P/E ratio | 29.4x | 28.6x | 24x | 19.6x |
| PBR | 4.57x | 5.16x | 4.33x | 3.62x |
| PEG | - | 0.7x | 1.3x | 0.9x |
| Capitalization / Revenue | 2.57x | 3.02x | 2.67x | 2.39x |
| EV / Revenue | 2.64x | 3.1x | 2.7x | 2.33x |
| EV / EBITDA | 14.2x | 15.9x | 13.4x | 11.1x |
| EV / EBIT | 19.2x | 20.7x | 16.9x | 13.7x |
| EV / FCF | 33x | 35.2x | 24.2x | 21.6x |
| FCF Yield | 3.03% | 2.84% | 4.13% | 4.63% |
| Dividend per Share 2 | 3 | 3.078 | 3.704 | 4.513 |
| Rate of return | 0.28% | 0.21% | 0.25% | 0.31% |
| EPS 2 | 36.43 | 50.96 | 60.7 | 74.33 |
| Distribution rate | 8.23% | 6.04% | 6.1% | 6.07% |
| Net sales 1 | 78,960 | 91,438 | 1,03,373 | 1,15,640 |
| EBITDA 1 | 14,689 | 17,830 | 20,823 | 24,277 |
| EBIT 1 | 10,847 | 13,709 | 16,494 | 19,671 |
| Net income 1 | 6,813 | 9,628 | 11,472 | 14,051 |
| Net Debt 1 | 4,904 | 6,742 | 2,122 | -6,494 |
| Reference price 2 | 1,072.40 | 1,458.40 | 1,458.40 | 1,458.40 |
| Nbr of stocks (in thousands) | 1,89,483 | 1,89,590 | - | - |
| Announcement Date | 22/05/25 | - | - | - |
1INR in Million2INR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 28.22x | 3.06x | 15.67x | 0.21% | 294.76Cr | ||
| 28.95x | 10.91x | 21.91x | 0.67% | 88TCr | ||
| 25.63x | 5.96x | 16.23x | 2.19% | 58TCr | ||
| 24x | 6.55x | 13.15x | 3.16% | 39TCr | ||
| 17.32x | 4.22x | 10.43x | 3.13% | 32TCr | ||
| 23.94x | 4.98x | 13.83x | 1.75% | 30TCr | ||
| 20.93x | 5.64x | 13.96x | 2.87% | 29TCr | ||
| 27.02x | 4.74x | 14.82x | 2.92% | 29TCr | ||
| 24.64x | 6.26x | 11.14x | 2.74% | 20TCr | ||
| 20.1x | 6.12x | 11.06x | 2.25% | 18TCr | ||
| Average | 24.07x | 5.84x | 14.22x | 2.19% | 34.29TCr | |
| Weighted average by Cap. | 24.73x | 6.94x | 15.71x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- EMCURE Stock
- Valuation Emcure Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















